Inactive Instrument

Iomai Corporation Share Price

Stocks

US46202P1030

Pharmaceuticals

End-of-day quote Nasdaq
- - Intraday chart for Iomai Corporation
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Corporate Officer/Principal 59 30/11/2015
Director of Finance/CFO 56 -
Corporate Officer/Principal - 31/07/2008
Director TitleAgeSince
Director/Board Member 87 04/07/2006
Director/Board Member 83 31/12/2005
Director/Board Member 73 31/12/2001
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-3.67%+15.66%-20.23% 62.28B
+1.44%+5.33%+68.19%+222.27% 60.59B
+0.70%+29.50%+29.50%+29.50% 39.55B
+0.26%+9.80%-54.99%-65.15% 36.8B
+0.05%+2.41%+53.12%-34.32% 29.53B
+0.65%+6.01%+60.19%+75.19% 21.68B
+0.54%+5.21%+87.14%-61.00% 19.8B
+4.80%-0.20%-5.27%+115.05% 16.96B
+0.18%-1.66%+54.11%+100.91% 16.16B
Average +0.97%+3.10%+34.18%+40.25% 33.71B
Weighted average by Cap. +0.80%+2.99%+31.76%+46.04%
Logo Iomai Corporation
Intercell USA, Inc. provides products for the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The Company is evaluating skin immunization techniques in several human clinical trials, including those to prevent influenza in the healthy adult and elderly populations, and also to prevent travelers' diarrhea and anthrax infection.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!